Aspen Aerogels (NYSE:ASPN) Reaches New 52-Week Low – Here’s What Happened

Aspen Aerogels, Inc. (NYSE:ASPN)’s share price reached a new 52-week low on Wednesday . The company traded as low as $7.45 and last traded at $7.50, with a volume of 2443166 shares traded. The stock had previously closed at $7.77.

Analysts Set New Price Targets

Several research analysts recently weighed in on the company. Craig Hallum dropped their target price on Aspen Aerogels from $21.00 to $18.00 and set a “buy” rating on the stock in a research note on Friday, February 14th. Barclays cut their price objective on shares of Aspen Aerogels from $25.00 to $13.00 and set an “overweight” rating on the stock in a report on Wednesday, February 19th. Canaccord Genuity Group lowered their target price on shares of Aspen Aerogels from $20.00 to $15.00 and set a “buy” rating for the company in a research note on Friday, February 14th. StockNews.com upgraded shares of Aspen Aerogels to a “sell” rating in a research note on Wednesday, February 19th. Finally, B. Riley dropped their price objective on shares of Aspen Aerogels from $35.00 to $22.00 and set a “buy” rating on the stock in a report on Wednesday, February 19th. One analyst has rated the stock with a sell rating, one has assigned a hold rating and nine have given a buy rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $22.44.

Aspen Aerogels Price Performance

The firm has a 50-day simple moving average of $11.44 and a two-hundred day simple moving average of $17.86. The company has a market capitalization of $614.96 million, a price-to-earnings ratio of 46.85 and a beta of 2.14. The company has a current ratio of 2.93, a quick ratio of 2.48 and a debt-to-equity ratio of 0.27.

Aspen Aerogels (NYSE:ASPN) last posted its earnings results on Wednesday, February 12th. The construction company reported $0.15 EPS for the quarter, topping the consensus estimate of $0.04 by $0.11. Aspen Aerogels had a return on equity of 7.49% and a net margin of 2.95%. As a group, analysts predict that Aspen Aerogels, Inc. will post 0.17 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Aspen Aerogels

Several institutional investors have recently made changes to their positions in the company. Toronto Dominion Bank acquired a new stake in Aspen Aerogels during the fourth quarter valued at $266,000. AWM Investment Company Inc. boosted its stake in shares of Aspen Aerogels by 2.9% during the 4th quarter. AWM Investment Company Inc. now owns 1,208,686 shares of the construction company’s stock worth $14,359,000 after acquiring an additional 34,115 shares in the last quarter. Connective Capital Management LLC acquired a new stake in shares of Aspen Aerogels during the 4th quarter valued at about $433,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its stake in shares of Aspen Aerogels by 47.3% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 588,395 shares of the construction company’s stock valued at $6,990,000 after purchasing an additional 188,861 shares in the last quarter. Finally, Voloridge Investment Management LLC acquired a new position in Aspen Aerogels in the 4th quarter worth about $3,089,000. 97.64% of the stock is owned by hedge funds and other institutional investors.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.